Multiple immune and inflammatory pathway components

The term Multiple immune and inflammatory pathway components refers to a broad and diverse set of molecular entities that coordinate the body's defense mechanisms and inflammatory responses. This category encompasses various cytokines, chemokines, cell surface receptors, and intracellular signaling molecules like Janus kinases (JAKs) and MAP kinases (Nature Reviews Immunology, 2017). These components function in complex, overlapping networks to maintain homeostasis and respond to pathogens or tissue damage. Dysregulation of these pathways is a primary driver of chronic inflammatory and autoimmune conditions, such as rheumatoid arthritis, Crohn's disease, and psoriasis (NIH, 2022). Because this is a collective term for many different proteins and signaling cascades, it does not represent a single, discrete therapeutic target. Instead, drug development focuses on specific, high-affinity targets within these pathways to achieve therapeutic effects while minimizing off-target toxicity (Frontiers in Pharmacology, 2021). Common therapeutic strategies include the use of monoclonal antibodies to neutralize specific cytokines or small molecules to inhibit key signaling enzymes.

Other names

Inflammatory mediatorsImmune system componentsCytokine signaling pathwaysInflammatory signaling cascades

Modulation of immune signaling through the inhibition of specific cytokines, receptors, or intracellular kinases involved in inflammatory cascades (Nature Reviews Drug Discovery, 2020).